Of note, our analysis has shown that increased ABLIM1 expression in HCC tissue samples predicts the shorter overall survival time, suggesting that ABLIM1 may be a potential prognosis biomarker for HCC. The gene discussed is ABLIM1; the disease is hepatocellular carcinoma.